As of 2025-12-29, the Relative Valuation of Alliance Pharma PLC (APH.L) is (20.72) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 64.70 GBP, the upside of Alliance Pharma PLC based on Relative Valuation is -132.0%.
The range of the Relative Valuation is (18.92) - (21.10) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.2x - 10.8x | 9.6x |
| Forward P/E multiples | 9.7x - 13.2x | 11.6x |
| Fair Price | (18.92) - (21.10) | (20.72) |
| Upside | -129.2% - -132.6% | -132.0% |
| Date | P/E |